BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/30/2019 5:42:15 AM | Browse: 961 | Download: 906
Publication Name World Journal of Pharmacology
Manuscript ID 44515
Country/Territory United Arab Emirates
Received
2018-11-14 03:51
Peer-Review Started
2018-11-14 09:26
To Make the First Decision
2018-12-10 00:23
Return for Revision
2018-12-18 06:14
Revised
2019-01-20 07:38
Second Decision
2019-01-26 09:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-01-28 20:42
Articles in Press
2019-01-28 20:42
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-01-29 08:41
Publish the Manuscript Online
2019-01-30 05:42
ISSN 2220-3192 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pharmacology & Pharmacy
Manuscript Type Review
Article Title Tobacco smoking and its drug interactions with comedications involving CYP and UGT enzymes and nicotine
Manuscript Source Unsolicited Manuscript
All Author List Naina Mohamed Pakkir Maideen
ORCID
Author(s) ORCID Number
Naina Mohamed Pakkir Maideen http://orcid.org/0000-0002-6950-9783
Funding Agency and Grant Number
Corresponding Author Naina Mohamed Pakkir Maideen, PhD, Pharmacist, Department of Pharmacy, Dubai Health Authority, Al Maktoum Bridge Street, Dubai 4545, United Arab Emirates. nmmaideen@dha.gov.ae
Key Words Drug Interactions; Tobacco Smoking; Cytochrome P450 enzymes; Uridine diphosphate-glucuronosyltransferases enzymes; Nicotine
Core Tip Use of medications among smokers is more common, nowadays. This review is aimed to identify the medications affected by smoking, involving cytochrome P450 (CYP) and uridine diphosphate-glucuronosyltransferases (UGTs) enzymes and Nicotine. The drugs metabolized by CYP1A1, CYP1A2, CYP2E1 and UGT enzymes might be affected by tobacco smoking and the smokers taking medications metabolized by those enzymes, may need higher doses due to decreased plasma concentrations through accelerated metabolism by Polycyclic aromatic hydrocarbons of tobacco smoke. The prescribers and the pharmacists are required to be aware of medications affected by tobacco smoking to prevent the toxicity-associated complications during smoking cessation.
Publish Date 2019-01-30 05:42
Citation Maideen NMP. Tobacco smoking and its drug interactions with comedications involving CYP and UGT enzymes and nicotine. World J Pharmacol 2019; 8(2): 14-25
URL https://www.wjgnet.com/2220-3192/full/v8/i2/14.htm
DOI https://dx.doi.org/10.5497/wjp.v8.i2.14
Full Article (PDF) WJP-8-14.pdf
Full Article (Word) WJP-8-14.docx
Manuscript File 44515-Review.docx
Answering Reviewers 44515-Answering reviewers.pdf
Audio Core Tip 44515-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 44515-Conflict-of-interest statement.pdf
Copyright License Agreement 44515-Copyright license agreement.pdf
Peer-review Report 44515-Peer-review(s).pdf
Scientific Editor Work List 44515-Scientific editor work list.pdf